Biotech · Private company
Connect Biopharm LLC
Track this companyFree. Adds Connect Biopharm LLC to your Dealase workspace and tells you when its record changes.
Clinical trials71 recruiting or active
Pipeline programs9From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline9
- CBP-201Phase 2 · Chronic Rhinosinusitis With Nasal PolypsClinicalTrials.gov · fetched Nov 12, 2026
- CBP-201Phase 2 · Moderate-to-severe Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- CBP-201Phase 2 · Moderate to Severe Persistent AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- Double-Blind 0.1mg CBP-307Phase 2 · Moderate to Severe Ulcerative ColitisClinicalTrials.gov · fetched Nov 12, 2026
- Double-Blind 0.2mg CBP-307Phase 2 · Moderate to Severe Ulcerative ColitisClinicalTrials.gov · fetched Nov 12, 2026
- Open-label CBP-307Phase 2 · Moderate to Severe Ulcerative ColitisClinicalTrials.gov · fetched Nov 12, 2026
- RademikibartPhase 2 · Asthma AcuteClinicalTrials.gov · fetched Nov 12, 2026
- Rademikibart in prefilled syringePhase 2 · Asthma AcuteClinicalTrials.gov · fetched Nov 12, 2026
- Rademikibart in prefilled syringePhase 2 · COPD Acute ExacerbationClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials7
- Rademikibart IV for Acute Asthma and COPD ExacerbationPHASE2 · RECRUITING · started Aug 21, 2026ClinicalTrials.gov NCT07705737 · fetched Nov 12, 2026
- Rademikibart Add-on Treatment of an Acute COPD Exacerbation (Seabreeze STAT COPD)PHASE2 · COMPLETED · started Aug 12, 2025ClinicalTrials.gov NCT06940154 · fetched Nov 12, 2026
- Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma)PHASE2 · COMPLETED · started Aug 8, 2025ClinicalTrials.gov NCT06940141 · fetched Nov 12, 2026
- A Study to Evaluate CBP-201, Rademikibart, in Adult Patients With Chronic Rhinosinusitis With Nasal PolypsPHASE2 · TERMINATED · started Jun 16, 2021ClinicalTrials.gov NCT04783389 · fetched Nov 12, 2026
- Efficacy and Safety of CBP-201 in Patients With Moderate to Severe Persistent Asthma With Type 2 InflammationPHASE2 · COMPLETED · started May 11, 2021ClinicalTrials.gov NCT04773678 · fetched Nov 12, 2026
- A Study to Assess the Efficacy and Safety of CBP-201 in Adult Subjects With Moderate to Severe Atopic DermatitisPHASE2 · COMPLETED · started Jul 17, 2020ClinicalTrials.gov NCT04444752 · fetched Nov 12, 2026
- A Study Assessing the Efficacy and Safety of CBP-307 in Subjects With Moderate to Severe Ulcerative Colitis (UC)PHASE2 · COMPLETED · started Feb 27, 2019ClinicalTrials.gov NCT04700449 · fetched Nov 12, 2026